MCP-1, not MIP-1α, is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures

Blood

Volumn 92, Issue 7, 1998, Pages 2338-2344

  Cashman, J D ^b   Eaves, C J ^b   Sarris, A H ^b   Eaves, A C ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0032190067     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2338     Document Type: Article

References (50)

1. Hodgson GS, Bradley TR: Properties of hematoppietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell? Nature 281:381, 1979
2. Eaves CJ, Eaves AC: Cell culture studies in CML, in Hinton K (ed): Bailliere's Clinical Haematology. London, UK, Bailliere Tindall/ Saunders, 1987, p 931
3. Bradford GB, Williams B, Rossi R, Bertoncello I: Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol 25:445, 1997
4. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL: The aging of hematopoietic stem cells. Nature Med 2:1011, 1996
5. Becker AJ, McCulloch EA, Siminovitch L, Till JE: The effect of differing demands for blood cell production on DNA synthesis by hemopoietic colony-forming cells of mice. Blood 26:296, 1965
6. Fauser AA, Messner HA: Proliferative state of human pluripotent hemopoietic progenitors (CFU-GEMM) in normal individuals and under regenerative conditions after bone marrow transplantation. Blood 54:1197, 1979
7. Harrison DE, Lerner CP: Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78:1237, 1991
8. Kaushansky K, Lin N, Adamson JW: Interleukin 1 stimulates fibroblasts to synthesize granulocyte -macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. J Clin Invest 81:92, 1988
9. Yang YC, Tsai S, Wong GG, Clark SC: Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J Cell Physiol 134:292, 1988
10. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
11. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
12. Lisovsky M, Braun SE, Ce Y, Takahira H, Lu L, Savchenko VG, Lyman SD, Broxmeyer HE: Flt3-ligand production by human bone marrow stromal cells. Leukemia 10:1012, 1996
13. Allen TD, Dexter TM: The essential cells of the hemopoietic microenvironment. Exp Hematol 12:517, 1984
14. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B: Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328:429, 1987
15. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985
16. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
17. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
18. Cashman JD, Eaves AC, Eaves CJ: Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells. Leukemia 6:886, 1992
19. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein la, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA90:12015, 1993
20. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P: Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 150:3448, 1993
21. Cashman JD, Eaves AC, Eaves CJ: The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism. Blood 84:1534, 1994
22. Otsuka T, Eaves CJ, Humphries RK, Hogge DE, Eaves AC: Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells. Leukemia 5:861, 1991
23. Sarris AH, Broxmeyer HE, Wirthmueller U, Karasavvas N, Cooper S, Lu L, Krueger J, Ravetch JV: Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J Exp Med 178:1127, 1993
24. Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291, 1983
25. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood 88:3765, 1996
26. Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh KO, Tekamp-Olson P, Kwon BS, Cerami A: Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76:1110, 1992
27. Otsuka T, Thacker JD, Eaves CJ, Hogge DE: Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells. J Clin Invest 88:417, 1991
28. Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC: Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88:2162, 1996
29. Rollins BJ: Chemokines. Blood 90:909, 1997
30. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 15:675, 1997
31. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344:442, 1990
32. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583, 1995
33. Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE: Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1α. J Immunol 149:1004, 1992
34. Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE: High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem 270:23282, 1995
35. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RVJ, Broxmeyer HE, Charo IF: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552, 1997
36. + cells purified from cord blood and fetal liver. Exp Hematol 23:422, 1995
37. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79, 1993
38. Hogge DE, Sutherland HJ, Cashman JD, Lansdorp PM, Humphries RK, Eaves CJ: Cytokines acting early in human haematopoiesis, in Brenner MK (ed): Cytokines and Growth Factors. London, UK, Bailliere Tindall, 1994, p 49
39. Sutherland HJ, Hogge DE, Cook D, Eaves CJ: Alternative mechanisms with and without Steel factor support primitive human hematopoiesis. Blood 81:1465, 1993
40. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601, 1998
41. 4L Graham GJ, Pragnell IB: SCI/MIP-1α: A potent stem cell inhibitor with potential roles in development. Dev Biol 151:377, 1992
42. Wang JM, Sherry B, Fivash MJ, Kelvin DJ, Oppenheim JJ: Human recombinant macrophage inflammatory protein-1α and -β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol 150:3022, 1993
43. Nibbs RJB, Wylie SM, Yang J, Landau NR, Graham GJ: Cloning and characterization of a novel promiscuous human β-chemokine receptor D6. J Biol Chem 272:32078, 1997
44. Charo LF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxylterminal tails. Proc Natl Acad Sci USA 91:2752, 1994
45. Sarau HM, Rush JA, Foley JJ, Brawner ME, Schmidt DB, White JR, Barnette MS: Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: A model system to examine the role of chemokines in cell function. J Pharmacol Exp Ther 283:411, 1997
46. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, Steiner DF: Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNACell Biol 16:1249, 1997
47. Monteclaro FS, Charo IF: The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1α receptor, confers chemokine selectivity. J Biol Chem 271:19084, 1996
48. Schulz-Knappe P, Magert H-J, Dewald B, Meyer M, Cetin Y, Kubbies M, Tomeczkowski J, Kirchhoff K, Raida M, Adermann K, Kist A, Reinecke M, Sillard R, Pardigol A, Uguccioni M, Baggiolini M, Forssmann W-G: HCC-1, a novel chemokine from human plasma. J Exp Med 183:295, 1996
49. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, Bell GI, Takeda J, Aronica S, Gordon M, Cooper S, Broxmeyer HE, Klemsz MJ: Cloning and characterization of exodus, a novel β-chemokine. Blood 89:3315, 1997
50. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G: Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 185:1163, 1997